Zecuity is a patch prescribed to treat migraine headaches in adults. The Zecuity patch contains sumatriptan and delivers treatment by a single-use, battery-powered patch that is wrapped around the upper arm or thigh.
The FDA is investigating the risk of serious burns and potential permanent scarring with the use of Zecuity patch for migraine headaches.
Since it was approved in September 2015 a large number of patients have reported they experienced burns or scars on the skin where the patch was worn. The reports included descriptions of severe redness, pain, skin discoloration, blistering, and cracked skin.
As of June 13, 2016 Zecuity manufacturer Teva Pharmaceuticals has suspend sales, marketing, and distribution to investigate the cause of burns and scars associated with the Zecuity patch and advised health care professionals to discontinue prescribing Zecuity.FDA Safety Alert on Zecuity Migraine Patch
Dobbs & Tittle has experience handling drug cases like this, and we are following this issue closely. If you or someone you know has been injured by the Zecuity migraine patch, we encourage you to contact us to find out more. Our consultations are confidential, provided free, and without obligation.
© Copyright 2018 Dobbs & Tittle, P.C. - All Rights Reserved